EP2607366A1 — Glycerol phenyl butyrate esters
Assigned to Lunamed AG · Expires 2013-06-26 · 13y expired
What this patent protects
The present invention refers to Glycerol Phenyl Butyrate Esters, including esters and amides, their stereoisomers, enantiomers, racemates as well as the acids, bases or salts thereof, medicaments comprising them, as well as their use in cancer therapy and other pharmaceutical app…
USPTO Abstract
The present invention refers to Glycerol Phenyl Butyrate Esters, including esters and amides, their stereoisomers, enantiomers, racemates as well as the acids, bases or salts thereof, medicaments comprising them, as well as their use in cancer therapy and other pharmaceutical applications. wherein one of R 1 , R 2 or R 3 is
Drugs covered by this patent
- Ravicti (GLYCEROL PHENYLBUTYRATE) · Horizon Therap Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.